RAMYRO BCD
AI powered Multi Modal Breast Cancer Diagnosis Solution
Overview
RAMYRO-BCD is an advanced AI-powered breast cancer detection solution designed to significantly reduce false negative rates, using a unique and highly optimized approach to achieve near-zero false negatives. It streamlines the breast cancer diagnosis process by quickly filtering out healthy patients, enabling radiologists to focus on cases that require attention, all with unmatched accuracy.
Mammo Quantify is an advanced AI tool for precise analysis of mammograms, assisting in quantifying abnormalities in breast tissue. It helps radiologists make more informed diagnostic decisions and ensures accurate detection of potential cancerous growths.
The solution detects abnormalities from mammography and ultrasound images
Mammography AI
Detect Masses, BIRAD Calcifications and breast density
Breast Ultrasound AI
Segmentation and Classification of breast ultrasound images
Key Features
- Segement, classifiy and provides detailed quantification of breast tissue abnormalities in mammography image
- Segement and classifiy abnormalities in breast ulrasound images as well.
- Achieves near-zero false negative rates by employing a finely tuned AI algorithm that ensures high precision in cancer detection.
- Detection of Masses, Calcifications, and breast density in Mammography images.
- Automatically prioritizes patients based on detected abnormalities and clinical risk factors, using an advanced risk-ranking system.
- Generates comprehensive reports automatically, helping radiologists save time and improve the accuracy of their diagnosis.
- Offers full transparency through explainable AI, ensuring clinicians can understand and trust the results provided by the system.